文献速递角膜与眼表疾病眼整形与眼眶

超厚羊膜移植用于眼表重建

Super-Thick Amniotic Membrane Graft for Ocular Surface Reconstruction.
PubMed 文献 · Am J Ophthalmol · 2018-10-09

结果显示移植物易于缝合且相对持久,全部病例上皮化且无伤口裂开,但16.7%发生继发性睑球粘连,83.3%实现完全局部肿瘤控制。

要点

  • ST-AMG厚度可达标准羊膜的9倍,可用7-0 Vicryl缝线连续或间断缝合而不切割。
  • 全部病例术后1周移植物位置良好,3周时75%出现部分移植物溶解。
  • 全部病例实现完全上皮化且无伤口裂开,继发性睑球粘连发生率为16.7%。

核心结论

  • ST-AMG易于缝合且相对持久,可实现眼表上皮化且不形成原发性睑球粘连,可作为眼表重建的替代选择。

研究设计与样本

  • 回顾性、干预性病例系列研究,单中心临床实践,纳入需重建的典型大面积眼表异常患者。

主要发现

  • ST-AMG厚度可达标准羊膜移植物的9倍,可用7-0 Vicryl缝线连续和间断缝合而不发生切割。
  • 全部病例术后1周ST-AMG位置良好,75%(n=9)在3周时出现部分移植物溶解。
  • 全部病例实现完全上皮化且无伤口裂开,但16.7%(n=2)在额外肿瘤治疗后形成继发性睑球粘连。
  • 全部病例在结膜重建及后续二次治疗期间平均视力和眼压保持不变。
  • 平均随访25.5个月(中位数10,范围3-90)时,10例(83.3%)实现完全局部肿瘤控制,1例巩膜融解再血管化,1例需眶内容物剜除。

关键数值与推荐

  • 术后1周评估移植物位置,3周评估移植物溶解,同时观察眼表上皮化和睑球粘连。
  • 50%(n=6)在上皮化后接受辅助局部化疗以扩展治疗边缘并治疗 presumed 隐匿病变。

临床怎么用

  • 对于大面积眼表异常需重建的病例,可考虑使用ST-AMG作为移植材料。
  • 术后需关注移植物溶解(3周时约75%部分溶解)及继发性睑球粘连的发生。

局限性

  • 随访时间不等(范围3-90个月),部分病例随访较短。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate super-thick amniotic membrane grafts (ST-AMGs) for ocular surface reconstruction. DESIGN: Retrospective, interventional case series. METHODS: This was a single-center study of clinical practice that included select patients with typically large ocular surface abnormalities that required reconstruction. The intervention studied was surgical insertion of a ST-AMG for reconstruction or repair of the ocular surface. Main outcome measures included intraoperative handling, graft position at 1 week post implantation, graft dissolution at 3 weeks, epithelialization of the ocular surface and symblepharon. RESULTS: Eleven ST-AMGs were implanted after resection with cryotherapy: 5 conjunctival melanoma, 4 squamous cell carcinoma, 1 sebaceous carcinoma, and 1 atypical pterygium. In addition, 1 was implanted for scleral necrosis. ST-AMGs were up to nine times thicker than standard amniotic grafts and were therefore amenable to both running and interrupted 7-0 Vicryl sutures without cheese-wiring. All cases had a well-positioned ST-AMG at 1 week and 75% (n = 9) had partial graft dissolution at 3 weeks. Complete epithelialization without wound dehiscence was noted in all cases. However, secondary (after additional tumor treatment) symblepharon formed in 16.7% (n = 2). In all cases, the mean visual acuity and intraocular pressures remained unchanged during conjunctival reconstruction and subsequent secondary treatments. Post epithelialization adjuvant topical chemotherapy was given to extend treatment margins and treat presumed occult disease in 50% (n = 6). At mean follow-up of 25.5 months (median 10, range 3-90), 10 cases (83.3%) showed complete local tumor control, 1 showed revascularization of the scleral melt, and 1 required orbital exenteration. CONCLUSION: ST-AMGs were easy to suture and relatively persistent. Epithelialization of the ocular surface without primary symblepharon formation was noted. ST-AMGs should be considered an alternative for ocular surface reconstruction.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Finger PT, Jain P, Mukkamala SK, et al. Super-Thick Amniotic Membrane Graft for Ocular Surface Reconstruction. Am J Ophthalmol. 2018. PMID: 30312574. doi:10.1016/j.ajo.2018.09.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。